> Details

Krebs, M.G.; Lin, J.J.; Pal, N.; Polito, L.; Trinh, H.T.L.; Hilton, M.M.S.M.; Smoljanovic, V.; Kurtsikidze, N.; Archer, V.; Zhang, Q.

1201P Real-world comparative effectiveness of 1L alectinib (ALC) vs crizotinib (CRZ) in patients (pts) with ALK+ advanced NSCLC with or without baseline CNS metastases (mets)

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: 1201P Real-world comparative effectiveness of 1L alectinib (ALC) vs crizotinib (CRZ) in patients (pts) with ALK+ advanced NSCLC with or without baseline CNS metastases (mets)
  • Contributor: Krebs, M.G.; Lin, J.J.; Pal, N.; Polito, L.; Trinh, H.T.L.; Hilton, M.M.S.M.; Smoljanovic, V.; Kurtsikidze, N.; Archer, V.; Zhang, Q.
  • Published: Elsevier BV, 2021
  • Published in: Annals of Oncology, 32 (2021), Seite S959
  • Language: English
  • DOI: 10.1016/j.annonc.2021.08.1806
  • ISSN: 0923-7534
  • Origination:
  • Footnote:
  • Access State: Open Access